Previous 10 | Next 10 |
Gainers: Seneca Biopharma (NASDAQ: SNCA ) +126% . More news on: Seneca Biopharma, Inc., iMedia Brands, Inc., Aptinyx Inc., Stocks on the move, , Read more ...
InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...
Gainers: Cemtrex (NASDAQ: CETX ) +100% . More news on: Cemtrex, Inc., OrganiGram Holdings Inc., Fluent, Inc., Stocks on the move, , Read more ...
Aptinyx (NASDAQ: APTX ) is up 10.6% after hours following news it's closed its public equity offering with a full exercise of the greenshoe option, and insiders bought several hundred thousands of dollars worth of shares. More news on: Aptinyx Inc., Healthcare stocks news, Stocks on the ...
Gainers: FLNT +59.8% . OGI +27.8% . APTX +9.3% . MNTA +4.8% . OTCQB:CURR +2.0% . More news on: Fluent, Inc., OrganiGram Holdings Inc., Aptinyx Inc., Stocks on the move, , Read more ...
EVANSTON, Ill., Jan. 14, 2020 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ:APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced the closing of its public offering of 11,691,666 shares of it...
Aptinyx (NASDAQ: APTX ) has priced its public offering of ~10.2M common shares at $3.00 per share, for expected gross proceeds of ~$30.5M. More news on: Aptinyx Inc., Healthcare stocks news, Stocks on the move, Read more ...
Portola Pharmaceuticals (NASDAQ: PTLA ) -41% on preliminary Q4 and FY 2019 results. More news on: Portola Pharmaceuticals, Inc., cbdMD, Inc., Naked Brand Group Limited, Stocks on the move, Read more ...
EVANSTON, Ill., Jan. 10, 2020 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ:APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced the pricing of its public offering of 10,166,666 shares of it...
EVANSTON, Ill., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that it intends to offer and sell shares of its common stock...
News, Short Squeeze, Breakout and More Instantly...
Signature Bank (SBNY) is expected to report for Q3 2023 BHP Group Ltd. (BHP) is expected to report for Q1 2024 Sorrento Therapeutics Inc. (SRNEQ) is expected to report $-0.15 for Q3 2023 Baran Group Ltd. (BRANF) is expected to report for quarter end 2023-09-30 World Copper (WCUFF)...
GLG Life Tech Corporation (GLGLF) is expected to report for Q1 2024 Accenture plc Class A (Ireland) (ACN) is expected to report $3.14 for Q1 2024 Greenlane Holdings Inc. (GNLN) is expected to report $-2.7 for Q3 2023 iMedia Brands Inc. (IMBIQ) is expected to report for quarter end 202...
Axcella Health Inc. (AXLA) is expected to report for Q3 2023 Telekom Malaysia Bhd (MYTEF) is expected to report for quarter end 2023-09-30 Atento S.A. (ATTOF) is expected to report for Q3 2023 Scryb Inc Com (SCYRF) is expected to report for Q4 2023 BHP Group Ltd. (BHP) is expected...